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Sex differences in chronic pain are reported to emerge during adolescence, 
although it is unclear if this includes responses to treatment. We conducted a meta-
analysis to examine whether sex differences were present on outcome variables at pre-
treatment, and whether the efficacy of psychological therapies for pediatric chronic pain 
differs between boys and girls at post-treatment and follow-up time points. Searches were 
conducted, extending two existing Cochrane reviews of randomized-controlled trials 
examining the efficacy of psychological therapies for chronic and recurrent pain in 
children and adolescents. Forty-six articles were eligible for inclusion, and data were 
extracted regarding pain, disability, anxiety, and depression in boys and girls at pre-
treatment, post-treatment, and follow-up time points. No published study reported 
outcome data separately by sex, so authors of all studies were contacted and 17 studies 
provided data. Twice as many girls (n =1760) were enrolled into clinical trials of 
psychological therapies for pediatric chronic pain than boys (n = 828). Girls reported 
higher depression and anxiety at pre-treatment than boys. Girls with headache also 
reported significantly greater pre-treatment pain severity. Treatment gains were 
consistent across the sexes. One exception was for post-treatment disability in children 
with non-headache pain conditions; girls exhibited a significant effect of treatment 
relative to control condition (SMD= -0.50[-0.80,-0.20], p < .01), but no such effect was 
observed for boys (SMD= -0.08[-0.44,0.28], p = .66). Future research should examine 
whether mechanisms of treatment efficacy differ between boys and girls, and consider the 
impact of pre-treatment sex differences on response to treatment. 
 
Keywords: sex differences; psychological therapy; chronic pain; children; adolescents; 
systematic review; meta-analysis 
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1. Introduction  
Evidence for psychological therapy for chronic pain is characterized by 
heterogeneity of sample, treatment content, and effect [61] . The next generation of 
therapies will need to be sensitive to individual differences and tailor treatment for 
specific effects [9] . Accounting for sex (male/female) and gender (characteristics, 
attributes, behaviours that society/culture considers masculine or feminine) can help 
contextualise pain behaviour [88] . We know sex matters for pharmacological treatments; 
it influences treatment-seeking behaviours, responses to analgesics, and even provider’s 
responses to individuals with pain [36,40,56,63] . But we do not know if, or how, sex 
affects psychological interventions for pain  [20] .  
Epidemiologically, sex differences in chronic pain prevalence appear in 
adolescence [18,21,45] , reflecting theories that sex hormones emerging during puberty 
explain the differential experience of pain in males and females [4,29,79] . However, 
alongside these biological explanations, male-female differences have their origins in 
early social-developmental periods in which children learn to express and behave in a 
gender-specific way when in pain. Girls are thought to be socialized to express feelings 
and seek support whereas boys are expected to be stoic [73,81] . In chronic pain, girls 
report using more social support seeking, while boys use more distraction to cope with 
pain [43,55] . Girls in chronic pain and community samples appear to engage in more 
catastrophizing, particularly rumination [13,43] , and girls with chronic pain report fewer 
positive pain-related self-statements [32] . Given these coping differences, it is reasonable 
to hypothesize that the few observations we have of differential treatment efficacy by 
patient sex [30,65]  may actually reflect a general, if unexamined, pattern. 
Although it is important to consider male-female variation in treatment responses, 
the majority of clinical trials for psychological therapies in children and adolescents are 
not directly designed to study this possibility. Samples sizes are often too small to 
reliably detect such effects, making it difficult to determine whether sex impacts the 
efficacy of psychological therapies for chronic pain in children and adolescents. The 
number of clinical trials in children has grown over the past few years [17,22] , and it is 
timely to consider pooling the data across these studies to explore whether sex 
differences are present in the efficacy of psychological therapies for pediatric chronic 
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pain. While this has been suggested for reviews of treatments for chronic pain, a recent 
study suggested that only 8% of reviews examine intervention sex effects [15] . 
We present a systematic review and meta-analyses to examine the influence of 
patient sex on the efficacy of psychological therapies for chronic and recurrent pain in 
children and adolescents. The primary aim was to explore sex differences in pain, 
disability, anxiety, and depression at pre-treatment, post-treatment, and follow-up time 
points. As gender is rarely measured in this literature, no explicit investigation of the 
impact of gender in psychological therapies for pediatric chronic pain was conducted. 
However, a secondary aim was to measure sex and gender reporting practices within 
trials, and findings interpreted considering the potential contributions of sex and gender. 
 
2. Methods 
This review was registered on the Prospero register of systematic reviews 
(registration number: CRD42015017848). The PRISMA (Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses) guideline was used to guide reporting. Figure 1 
provides the PRISMA flow diagram [60] for the current study. 
----------------- 
Figure 1 here 
----------------- 
2.1 Search strategy 
Searches were based on the strategies from two existing Cochrane reviews of 
psychological therapies for chronic pain in children and adolescents: 1) ‘Psychological 
therapies for the management of chronic and recurrent pain in children and adolescents’  
[17] and 2) ‘Psychological therapies (remotely delivered) for the management of chronic 
and recurrent pain in children and adolescents’ [22] . These existing reviews were 
chosen as a starting point because of the rigorous nature of such reviews, which are the 
standard for evaluating and synthesizing the results from clinical trials. All articles 
included in the original reviews were considered for possible inclusion in the present 
review. Additionally, the searches from the original reviews were updated since the time 
of the last search, and new articles were screened for eligibility. 
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2.2 Eligibility criteria and screening 
 Eligibility criteria for the present analyses required that included articles be: (1) a 
randomized-controlled trial (RCT) published in English in a peer-reviewed journal; (2) at 
least one arm of the included trial must be a credible, primarily psychological 
intervention with the aim of changing thoughts, behaviours, and/or mood of the 
individual to assist with coping with chronic pain; (3) have at least 10 participants in each 
treatment arm at each extracted time point; (4) include participants (defined as children 
and adolescents where the majority of the sample was age 18 years or younger) with 
chronic, non-cancer pain.  
Forty-four articles were identified from the original Cochrane reviews. Additional 
articles were identified by updating searches from the Cochrane reviews since last 
publication. The updated search was run on March 24, 2015 for all articles added to the 
databases since the time of the last search (464 before duplicates removed from the 
update of the review by Eccleston and colleagues [17]  on in-person psychological 
therapies, and 229 before duplicates removed from the update of the review by Fisher and 
colleagues  [22]  of remotely-delivered interventions). Once duplicates were removed, 
523 titles remained and were screened for eligibility by two co-authors (K.E.B. and 
E.K.), disagreements were resolved through discussion. After title screening, 39 full-text 
articles were screened by two co-authors (K.E.B. and E.K.) to determine eligibility for 
inclusion. Of these, two were eligible for inclusion [5,33] . Thirty-seven articles were 
excluded for the following reasons: 5 were not an RCT, 1 described a study protocol, 1 
did not include a sample of only chronic pain patients, 1 study focused on adherence 
rather than treatment of chronic/recurrent pain patients, 8 had adult samples, 2 had 
insufficient psychotherapeutic content, 12 were conference abstracts, 3 did not have the 
full-text available in English, and 1 was a dissertation. Additionally, three articles were 
deemed eligible [38,54,78] , but reported secondary/additional analyses of trials that had 
already been included in the Cochrane reviews, so were not included [42,53] . In total, 46 
articles were identified as being eligible for data extraction. 
Each of the eligible articles were read and data were extracted by a study author 
(K.E.B.) using an author-created data extraction form that documented sample 
characteristics, treatment characteristics, reporting practices for sex and gender variables, 
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and measures of pain, disability, anxiety, and depression at pre-treatment, post-treatment, 
and follow-up. Data extraction was checked by a second study author (E.K.). Consistent 
with the previous Cochrane reviews [17,22] , post-treatment was defined as the first 
assessment point after treatment had been completed. Follow-up was defined as the 
assessment point between 3 and 12 months following the end of treatment; if more than 
one follow-up assessment was available, the latter time-point was extracted1. For studies 
in which a wait-list control design was employed, data were not extracted for any follow-
up time-points in which the control group had received treatment. When both parent-
report and child-self-report were available for outcomes, child self-report was extracted.  
Consistent with the previous Cochrane reviews [17,22] , outcomes were analysed 
separately for headache and non-headache pain conditions, in attempt to minimize 
heterogeneity within the groups with regards to pain characteristics and measurement of 
outcomes. For headache pain outcomes, pre-treatment outcomes were extracted as 
continuous data, and post-treatment and follow-up outcomes were extracted as 
continuous data as well as dichotomous clinical reduction in headache severity (i.e., how 
many participants did/did not experience at least a 50% improvement from pre- to post-
treatment). In accordance with the recommendations of the International Headache 
Society and the American Headache Society, headache frequency was considered the 
primary outcome of interest and was prioritized during data extraction [68] . If headache 
frequency was not available, headache pain intensity or duration was extracted. 
Consistent with previous reviews [22] , headache pain outcomes are referred to as 
‘headache severity’. For all other outcomes, the most appropriate measure was used, as 
per the previously published Cochrane reviews [17,22] . Readers are referred to the 
previously published Cochrane reviews for a complete list of which measures were 
extracted for each outcome, noting that in some cases a proxy measure for the exact 
outcome was used (e.g., using a scale of stress or catastrophizing as a measure of 
anxiety), and occasionally the measure used was not described in the original RCT, but 
was mentioned in subsequent publications from the same dataset (for the sake of 
                                                 
1 Note that for Levy et al. 2010 [53]  data from the 6-month time point (the latest follow-
up point reported in the original manuscript) were used in the present meta-analysis. 
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consistency, we always refer to only the original publication of the RCT in the present 
manuscript).  
For studies that included mixed groups of both headache and non-headache, 
authors were asked to provide data for each group separately [31] , however, if this was 
not possible data were included in both analyses as appropriate [34,66] . If any of the 
outcome measures at any time-point were not available separately for each sex, authors 
were contacted and asked to supply the missing data. For each case of missing data, 
authors were contacted no more than twice. Of the 44 requests for data made, 17 
responses (38.6%) provided the requested data  
[1,3,5,7,11,27,28,31,34,42,53,66,69,70,80,83,84] . Thirteen responses (29.5%) indicated 
that the data was no longer available [10,12,37,46,49,51,57,58,64,67,71,75,76] , the 
authors of 14 studies could not be contacted or did not reply to the request for data  
[6,16,19,26,47,48,50,52,72,77,82,85,86] , and authors of two eligible studies were not 
contacted, as they did not measure any of the extracted outcomes [24]  or the sample 
included only girls and could not be included in the meta-analysis of sex differences [41] 
. Table 1 summarizes the characteristics of the studies that were and were not included in 
the meta-analysis.   
----------------- 
Table 1 here 
----------------- 
2.3 Data analytic approach  
A minimum of two studies per comparison group was required to conduct meta-
analysis for a particular outcome. Studies needed to include both boys and girls to be 
included in the meta-analysis. Additionally, a minimum of two participants per group was 
required to include the study in a meta-analysis for a particular outcome (i.e., data needed 
to be available from at least two girls in the treatment group, two girls in the control 
group, two boys in the treatment group, and two boys in the control group). All data 
suitable for inclusion in the meta-analysis were analysed using RevMan 5.3 software, 
employing a random-effects model. For dichotomous outcomes (i.e., clinically significant 
reduction in headache severity), Mantel-Haenszel methods were used for analysis and the 
risk ratio (RR) was reported calculated using 95% confidence intervals (CI). To aid with 
SEX DIFFERENCES IN THERAPY FOR PEDIATRIC PAIN 
 8 
interpretation of the results, the number needed to treat to benefit (NNTB) was 
calculated. For continuous outcomes, standardised mean differences (SMD) were 
calculated, also reporting 95% CI. Heterogeneity, presented as the I2 statistic, was 
interpreted as per the guidelines from the Cochrane Handbook for Systematic Reviews of 
Interventions [35] , with 0-40% heterogeneity considered to be likely not important, 30-
60% and 50-90% representing moderate and substantial levels of heterogeneity 
respectively, and 75% or greater representing considerable heterogeneity.  
For the pre-treatment baseline time point, analyses were conducted to compare the 
differences on each outcome between boys and girls. For the post-treatment and follow-
up time points, the treatment condition was compared to the control condition separately 
for boys and girls, and subgroup analyses were conducted using a chi-square test to 
examine the differences between samples of boys and girls (i.e., whether the variability in 
effects between the subgroups of boys and girls was due to true sex differences and not 
due to chance). Subgroup analyses is an acceptable methods of examining sex effects in 
reviews  [15] . Studies were analysed all together, and then separately for headache and 
non-headache pain conditions. Forest plots for each of the analyses are available as 
Supplementary Material.  
Data examining the reporting practices of sex- and gender-related variables and 
analyses were summarized using descriptive statistics.  
 
3. Results 
 The following results present meta-analyses with data from the seventeen studies  
[1,3,5,7,11,27,28,31,34,42,53,66,69,70,80,83,84]  from which data split by sex was made 
available by study authors. Data were available from a grand total of 1164 participants 
(316 boys and 848 girls)2. The specific studies included and the respective sample sizes 
are provided for each individual analysis presented below.  
 
 
                                                 
2 Sample sizes was calculated based on the sample sizes provided by authors at the pre-
treatment time point (if sample sizes differed between outcomes, the largest sample size 
was included here). 
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3.1 Sex differences at pre-treatment baseline 
The statistics for the following meta-analyses examining overall differences 
between boys and girls at pre-treatment are provided in Table 2. 
----------------- 
Table 2 here 
----------------- 
3.1.1 Pain 
 All Chronic Pain Conditions. Data from fifteen studies 
[3,5,7,11,28,31,34,42,53,66,69,70,80,83,84] were entered into the meta-analysis, which 
revealed no differences in pain between girls and boys at the pre-treatment time point. 
 Headache. Data from eight studies [5,7,11,31,34,66,69,70] were entered into the 
meta-analysis, which revealed that girls reported significantly greater headache severity 
than boys at pre-treatment. 
 Non-Headache. Data from ten studies [3,28,31,34,42,53,66,80,83,84] were 
entered into the meta-analysis, which revealed no differences in pain between girls and 
boys at the pre-treatment time point. 
3.1.2 Disability 
 All Chronic Pain Conditions. Data from thirteen studies 
[1,7,11,28,31,42,53,66,69,70,80,83,84]  were entered into the meta-analysis, which 
revealed no differences in disability between girls and boys at the pre-treatment time 
point3. 
 Headache. Data from seven studies [1,7,11,31,66,69,70] were entered into the 
meta-analysis, which revealed that there were no significant differences in disability 
between girls and boys at the pre-treatment time point. 
 Non-Headache. Data from eight studies [28,31,42,53,66,80,83,84] were entered 
into the meta-analysis, which revealed no differences in disability between girls and boys 
at the pre-treatment time point. 
                                                 
3 Note that for the study by Barry and von Baeyer [7] , the mean and standard deviation of 
one of the groups (control group boys, n=6) was zero. As the RevMan software will not 
permit an entry with a standard deviation of zero, a value of 10-11 was entered as the 
standard deviation to perform the calculation. Removing this study from the analysis did 
not change the overall significance of the results. 
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3.1.3. Anxiety 
 All Chronic Pain Conditions. Data from five studies [31,42,53,80,83]  were 
entered into the meta-analysis, which revealed that girls reported significantly higher 
anxiety than boys at pre-treatment.   
 Headache. As only one study of headache [31] included a measure of anxiety 
appropriate for the present analysis, no analyses could be conducted regarding sex 
differences in pre-treatment anxiety.   
 Non-Headache. Data from five studies [31,42,53,80,83] were entered into the 
meta-analysis, which indicated that prior to entering treatment, girls with chronic non-
headache pain reported significantly greater anxiety than boys. 
3.1.4 Depression 
 All Chronic Pain Conditions. Data from five studies [31,42,53,66,83]  were 
entered into the meta-analysis, which revealed that girls reported significantly greater 
symptoms of depression than boys at pre-treatment.   
 Headache. Data from two studies [31,66] were entered into the meta-analysis, 
which revealed that girls reported significantly higher depression than boys at pre-
treatment.   
 Non-Headache. Data from five studies [31,42,53,66,83] were entered into the 
meta-analysis, which indicated that prior to entering treatment, girls with chronic non-
headache pain reported significantly greater symptoms of depression than boys. 
3.2 Outcomes at the post-treatment time point 
The meta-analysis statistics of treatment effect for boys and girls at the post-
treatment time point, and subgroup analyses examining sex differences, are provided in 
Table 3.  
----------------- 
Table 3 here 
----------------- 
3.2.1 Pain 
 All Chronic Pain Conditions. Data from fourteen studies 
[5,7,11,28,31,34,42,53,66,69,70,80,83,84] were entered into the meta-analysis, which 
compared pain between treatment and control groups at the post-treatment time point. 
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The analysis found that pain was significantly lower in the groups that received the 
psychological therapies compared to the control groups at post-treatment in both girls and 
boys4. The test of sex subgroup differences was not significant. 
 Headache. Data from eight studies [5,7,11,31,34,66,69,70] were entered into the 
meta-analysis which compared headache severity at the post-treatment time point 
between treatment and control groups. The analysis of treatment compared to control 
groups found that pain was significantly lower in the groups that received the 
psychological therapies compared to the control groups at post-treatment for both girls 
and boys5. The test of sex subgroup differences was not significant. 
Data from eight studies  [5,7,11,31,34,66,69,70] were entered into the meta-
analysis which compared the number of children in the treatment and control groups who 
had a clinically significant (50% or greater) reduction in headache severity at the post-
treatment time point. The analysis of treatment compared to control groups found that the 
number of patients who experienced a clinically significant reduction in headache 
severity at post-treatment was significantly greater in the psychological therapy treatment 
groups compared to the control group for girls (NNTB = 4.98), and boys (NNTB = 
3.34)6. The test of sex subgroup differences was not significant. 
 Non-Headache. Data from nine studies [27,28,31,34,42,53,66,80,83,84] were 
entered into the meta-analysis, which compared pain between treatment and control 
groups at the post-treatment time point. This effect of treatment was significant for both 
girls and boys. The test of sex subgroup differences was not significant. 
 
 
                                                 
4 All trials, with the exception of one, examined cognitive-behavioural or behavioural 
therapies. If the only trial evaluating psychodynamic psychotherapy is removed [5] , the 
effect becomes p = .05 for boys, stays significant for girls (p < .01), and there are still no 
significant subgroup differences (p= .79). 
5 All trials, with the exception of one, examined cognitive-behavioural or behavioural 
therapies. If the only trial evaluating psychodynamic psychotherapy is removed [5] , the 
effect of treatment is no longer significant (p = .08) for boys, but remains significant (p = 
.02) for girls, and there are no significant subgroup differences (p = .67). 
6 If the only trial evaluating psychodynamic psychotherapy is removed [5] , the effect of 
treatment remains significant for both girls (p = .04; NNTB = 5.05) and boys (p = .04; 
NNTB = 3.91), and there are no significant subgroup differences (p = .93). 
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3.2.2 Disability 
 All Chronic Pain Conditions. Data from thirteen studies 
[1,7,11,28,31,42,53,66,69,70,80,83,84]  were entered into the meta-analysis, which 
compared disability between treatment and control groups at the post-treatment time 
point. The analysis revealed that for girls disability was significantly lower at post-
treatment in the groups that received the psychological therapies than the control groups, 
but that this treatment effect was not observed in boys (i.e., there was no difference 
between treatment and control conditions at the post-treatment time point for boys). 
However, the test of sex subgroup differences was not significant. 
 Headache. Data from seven studies [1,7,11,31,66,69,70] were entered into the 
meta-analysis, which compared disability between treatment and control groups at the 
post-treatment time point for children with headache. The analysis of treatment compared 
to control groups revealed that disability was significantly lower at post-treatment in the 
groups that received the psychological therapies than the control groups for both girls and 
boys. The test of sex subgroup differences was not significant. 
 Non-Headache. Data from eight studies [28,31,42,53,66,80,83,84] were entered 
into the meta-analysis, which compared disability between treatment and control groups 
at the post-treatment time point. The analysis of treatment compared to control group for 
girls indicated that disability was significantly lower at post-treatment in the groups of 
girls that received the psychological therapies than the control groups. However, when 
the analysis was repeated with only the boys who participated in the included trials, there 
was no significant difference between the treatment and control groups. The test of sex 
subgroup differences indicated there was not a significant difference between boys and 
girls; though 67.8% of the variability in effect estimates between boys and girls at the 
post-treatment time point was due to genuine differences between the sex subgroups, 
rather than chance. 
3.2.3. Anxiety 
 All Chronic Pain Conditions. Data from five studies [31,42,53,80,83] were 
entered into the meta-analysis, which compared anxiety between treatment and control 
groups at the post-treatment time point. The analysis indicated that there was no 
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significant difference between treatment and control conditions on post-treatment anxiety 
for girls or boys. The test of sex subgroup differences was not significant. 
 Headache. As only one study of headache [31] included a measure of anxiety 
appropriate for the present analysis, no analyses could be conducted examining anxiety at 
the post-treatment time point in children with headache. 
 Non-Headache. Data from five studies [31,42,53,80,83] were entered into the 
meta-analysis, which compared anxiety at the post-treatment time point between 
treatment and control groups. The analysis of treatment compared to control groups 
indicated that anxiety did not differ significantly in the groups that received the 
psychological therapies than the control groups at post-treatment for both girls and boys. 
The test of sex subgroup differences was not significant. 
3.2.4 Depression 
 All Chronic Pain Conditions. Data from four studies [31,53,66,83] were entered 
into the meta-analysis, which compared depression between treatment and control groups 
at the post-treatment time point. The analysis indicated that there was no significant 
difference between treatment and control conditions on post-treatment depression for 
girls or boys. The test of sex subgroup differences was also not significant. 
 Headache. Data from two studies [31,66] were entered into the meta-analysis, 
which compared depression between treatment and control groups at the post-treatment 
time point for children with headache. The analysis indicated that there was no significant 
difference between treatment and control conditions on post-treatment depression for 
girls or boys. The test of sex subgroup differences was not significant. 
 Non-Headache. Data from four studies [31,53,66,83] were entered into the meta-
analysis, which compared depression between treatment and control groups at the post-
treatment time point. The analyses indicated that depression did not differ significantly in 
the groups that received the psychological therapies than the control groups at post-
treatment for girls or boys. The test of sex subgroup differences was not significant. 
3.3 Outcomes at the follow-up time point 
The meta-analysis statistics of treatment effect for boys and girls at the follow-up 
time point, and subgroup analyses examining sex differences, are provided in Table 4.  
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----------------- 
Table 4 here 
----------------- 
3.3.1 Pain 
 All Chronic Pain Conditions. Data from six studies [3,34,42,53,69,83] were 
entered into the meta-analysis, which compared pain at the follow-up time point between 
treatment and control groups. The analysis indicated that pain did not differ between the 
groups that received psychological therapies compared to the control groups at follow-up, 
both for girls and boys. The test of sex subgroup differences was not significant. 
 Headache. Data from two studies [34,69] were entered into the meta-analysis, 
which compared headache severity at the follow-up time point between treatment and 
control groups. The analysis indicated that for both girls and boys, pain did not differ 
between the groups that received psychological therapies compared to the control groups 
at the follow-up time point. The test of sex subgroup differences was not significant. 
Data from two studies  [34,69] were entered into the meta-analysis, which 
compared headache severity at the follow-up time point between treatment and control 
groups. The analyses indicated that there were no more children who had experienced a 
clinically significant reduction in headache severity at follow-up in the psychological 
therapy group compared to the control group in girls (NNTB = 4.68) or boys (NNTB = 
3.29). The test of sex subgroup differences was not significant. 
 Non-Headache. Data from five studies were entered into the meta-analysis 
[3,34,42,53,83] , which compared pain between treatment and control groups. The 
analyses indicated that pain was not significantly different at follow-up between the 
groups that received the psychological therapies and the control groups for girls and boys. 
The test of sex subgroup differences was not significant. 
 
3.3.2 Disability 
 All Chronic Pain Conditions. Data from five studies [1,42,53,69,83] were 
entered into the meta-analysis, which compared disability at the follow-up time point 
between treatment and control groups. The analysis indicated that there was no 
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significant difference between treatment and control conditions for girls or boys. The test 
of sex subgroup differences was not significant. 
 Headache. Data from two studies [1,69] were entered into the meta-analysis, 
which compared disability in children with headache at the follow-up time point between 
treatment and control groups. The analysis of treatment compared to control groups, 
indicating that at the follow-up time point children who received psychological therapies 
reported significantly lower disability compared to children in the control group, for both 
girls and boys. The test of sex subgroup differences was not significant. 
 Non-Headache. Data from three studies were entered into the meta-analysis 
[42,53,83]  which compared disability between treatment and control groups at the 
follow-up time point. The analyses indicated that disability at follow-up did not differ 
significantly in the groups that received the psychological therapies than the control 
groups for girls or boys. The test of sex subgroup differences was not significant. 
3.3.3. Anxiety 
 All Chronic Pain Conditions. Data from three studies [42,53,83] were entered 
into the meta-analysis, which compared anxiety between treatment and control groups at 
the follow-up time point. The analysis indicated that there was no significant difference 
between treatment and control conditions for girls or boys. The test of sex subgroup 
differences was not significant. 
 Headache. As none of the included studies reported a measure of anxiety at the 
follow-up time point that was appropriate for the present analysis, no analyses could be 
conducted for this outcome.   
 Non-Headache. The analyses for non-headache chronic pain included the same 
three studies [42,53,83] from the analysis described above examining anxiety at follow-
up for all chronic pain conditions. Please refer to the above analysis. 
3.3.4 Depression 
 All Chronic Pain Conditions. Data from three studies [42,53,83] were entered 
into the meta-analysis, which compared depression between treatment and control groups 
at the follow-up time point. The analysis indicated that there was no significant difference 
between treatment and control conditions for girls or boys. The test of sex subgroup 
differences was not significant. 
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 Headache. As none of the included studies reported a measure of depression at 
the follow-up time point that was appropriate for the present analysis, no analyses could 
be conducted for this outcome.   
 Non-Headache. The analyses for non-headache chronic pain included the same 
three studies [42,53,83] from the analysis described above examining depression at 
follow-up for all chronic pain conditions. Please refer to the above analysis. 
 
3.4 Reporting practices for sex- and gender-related variables 
 Terminology. Similar to what has been observed in experimental research on 
pediatric pain [8] , a variety of terminology was used to describe the distinction between 
boys and girls in the 46 included studies. “Sex” was used in 37% (n=17) of included 
RCTs, “gender” in 35% (n=16), and the remaining articles either used the two terms 
interchangeably (7%, n=3) or not at all (22%, n=10). All studies reported the number of 
boys and girls in the entire study sample, or this information could be inferred from the 
data provided, and the majority of studies also provided the number of each sex within 
each treatment arm (85%, n=39). One study did not include any male participants, though 
this was due to not having been successful in recruiting boys, rather than an intentional 
omission [41] .  
Sex distribution at enrolment and drop-outs. More than twice as many girls 
(n=1760) entered clinical trials as boys (n=828)7. Only 13% (n=6) of studies that 
included both boys and girls specified the sex of all participants that dropped out of the 
trial after randomization. Three additional studies did not indicate the sex of participants 
who dropped out of the trial, but conducted statistical tests to examine differences in 
                                                 
7 Total number enrolled includes all participants who entered into the trial and were 
randomized to a treatment condition, including participants who eventually dropped out 
of the trial or were lost to follow-up, wherever this information was available. Of note, 
approximately a quarter of studies provided only the sample size split by sex for 
participants who completed the trial, therefore the available information was used in 
calculating these totals. One study [80] reported different numbers of girls and boys in the 
table of demographic variables (15 boys, 31 girls) and the text (14 boys, 32 girls); the 
data from the table were extracted for the present tally. Additionally, one study [51]  
 described enrolling 44 girls, but that one withdrew during the baseline phase 
(presumably prior to randomization), and therefore only the 43 girls who were 
randomized were included in the present tally.   
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dropout sex (two studies reported no differences, one found boys to be more likely to 
drop out than girls), and three studies reported the sex of some but not all of the 
participants who dropped out, or sex could be inferred for some participants because of 
pronouns used in their description or the reason they dropped out of the trial (e.g., 
pregnancy).  
Clinician sex. A minority (24%, n=9) of studies where the therapy was conducted 
in-person (i.e., not including studies where therapist contact was primarily by email, 
phone, etc.) reported the sex of the therapist or clinician providing the intervention in the 
arm that was specified as the psychological treatment condition (or provided the 
name/identity of the clinician from which sex could be inferred), with female clinicians 
being more common in studies that did report this information (18 female clinicians; 3 
male clinicians)8.    
Consideration of sex in randomization, statistical analyses, and discussion. Of 
the 45 studies that included both boys and girls in their samples, many studies described 
attempts to evenly distribute participants across treatment groups based on sex and/or 
described statistical tests conducted to ensure a relatively equal distribution of boys and 
girls (76%, n=34). Three studies (7%) included sex as a covariate or corrected for sex in 
their statistical analyses. The majority of studies that had both girls and boys in their 
sample did not report conducting statistical tests to examine sex differences either pre- or 
post-treatment (82%, n=37). None of the studies that examined sex differences in 
treatment effects or pain outcomes found a significant difference between boys and girls. 
Two studies did report significant sex differences in headache (e.g., at pre-treatment), but 
not in relation to treatment outcomes [7,19] . None of the included studies examined the 
relationship between child sex and treatment outcomes as mediated or moderated by 
another variable, nor did they examine the relationship between another variable on 
treatment outcomes as mediated or moderated by child sex. Additionally, no studies 
employed a validated measure of child gender to examine the impact of the child’s 
endorsement of typically masculine or feminine behaviours on treatment outcomes. The 
majority of the 46 studies included (83%, n=38) did not discuss male-female differences 
                                                 
8 One study [7] did not list the sex of all therapists involved, but did describe that each 
session was co-led by one male and one female member of the team of therapists. 
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in the Discussion section of the paper. Those that did mention sex or gender differences 
in the Discussion primarily did so to indicate that a lack of examination of sex differences 
as a limitation of their study, or highlighted this issue as a direction for future research. 
 
4. Discussion  
We explored whether there were differences in boys and girls entered into 
published clinical trials of psychological treatments for chronic pain. Girls were more 
anxious and depressed than boys, and for headache trials, girls reported more pain at pre-
treatment. No sex differences were found for disability. In terms of treatment, effects 
reported in previous Cochrane reviews [17,22] were intact for boys and girls post-
treatment, with one exception: the previously reported positive effect of treatment on 
disability was only found for girls.  
These results suggest that treatment of psychological distress is important in girls 
presenting for treatment for chronic pain. Anxiety is related to poorer outcomes in 
cognitive-behavioural treatment of pediatric chronic pain [14] , and earlier intervention 
may be required for girls to prevent development of significant distress. Since this and 
the original Cochrane reviews [17,22] found no differences in anxiety and depression 
between treatment and control groups, there is a need to recognize distress in the 
treatment of chronic pain, particularly for girls. Additionally, amongst children with 
headache, girls reported significantly greater pain severity at pre-treatment than boys. 
Such pre-treatment differences are important to acknowledge, as the severity of initial 
symptom presentations may impact how an individual engages with treatment. 
The primary focus was to determine whether response to psychological treatment 
was consistent between boys and girls, both immediately post-treatment and at follow-up. 
Findings were similar to those reported in the original reviews that did not split by sex  
[17,22] . However, when we considered children with non-headache pain, psychological 
therapies were effective at reducing disability at post-treatment for girls but there was no 
significant difference in disability ratings amongst boys assigned to the treatment 
compared to controls. Given that boys and girls did not differ in pre-treatment disability, 
the findings cannot simply be explained by a ceiling effect with girls having more gains 
to be made than boys. It is possible that the disability measures did not tap into domains 
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that are relevant to boys. It is also possible that the treatment gains for disability in girls 
was related to their increased pre-treatment psychological distress (i.e., while treatment 
did not significantly impact anxiety or depression, addressing psychological functioning 
may have increased engagement in previously avoided activities, thus improving 
disability). There may be factors related to sex and gender (e.g., expectations around 
masculine responses to pain, such as stoicism and reluctance to share the emotional 
aspects of the experience) that account for a lack of response to psychological therapy. 
The subgroup analysis of sex differences was not significant (p = .08), and replication 
with larger samples are needed to determine whether this finding represents a true, 
although weak, sex difference. More than twice as many girls entered clinical trials than 
boys, which is counter to the general trend of underrepresentation of females that hinders 
gender-based investigations [23,25,39] . Whilst this may reflect the higher prevalence of 
chronic pain in adolescent girls compared to boys [45] , a large proportion of the patients 
enrolled were of pre-pubescent age (where sex differences in chronic pain is not as 
frequently observed), therefore this is not a complete explanation. The disproportionate 
representation of girls could reflect other sex-related factors, such as differences in 
healthcare referral practice, patient and/or parent willingness to engage in health care 
services, clinical trials, or psychological therapies for pain [2,44] . Overall, few treatment 
gains were reported for either boys or girls on the majority of outcomes, particularly at 
the follow-up. Although consistent with previous research [17,22] , the current findings 
illustrate the need for larger samples to enable consideration of sex differences in the 
long-term efficacy of psychological therapies for pediatric chronic pain.  
Similar to the general literature on clinical trials [23,74] , reporting practices 
around sex and gender were poor. No study reported outcomes separately for boys and 
girls, and so authors were contacted, and few reported on the sex of the therapist or 
clinician providing treatment. Previous research on therapeutic alliance and treatment 
completion in psychotherapy has shown that outcomes may be influenced by the sex-
match between adolescent patients and their therapist [87] . There is a need to examine 
whether aspects of treatment content are more beneficial for boys compared to girls, 
whether treatment delivery (e.g., male vs. female clinician, distance vs. in-person, 
individual vs. group) differs in efficacy and preferences for boys and girls, and whether 
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there are developmental or psychological (e.g., anxiety) considerations that interact with 
sex. Since few trials reported the sex of treatment dropouts, it is difficult to know whether 
this was proportionately equal between boys and girls. Such knowledge would help 
clinicians identify any systematic bias in dropout rates based on sex, and determine 
whether sex-specific treatment approaches may improve retention.  
 This review is subject to limitations typical of meta-analyses, including variability 
between treatment studies (e.g., differences in measures, lengths and format of treatment, 
treatment delivery etc.). As no data were suitable for extraction from the original 
published studies, analyses were subject to data made available from authors. Data were 
not available from many of the older studies (see Table 1), which tended to report on 
samples of adolescents. Much of the data included in the meta-analysis comprised 
primarily of children from the pre-pubescent age range, which may have introduced 
potential bias and contributed to the general lack of sex differences observed in treatment 
effects. Additionally, some study data were based on participants who completed the trial 
(i.e., excluded participants that were lost to follow-up or discontinued treatment even if 
they completed pre-treatment measures), while others provided all data available at each 
time-point regardless of dropouts. Samples were predominantly female, and may have 
meant analyses including girls were more likely to detect effects due to sample size. 
Heterogeneity tended to be larger for the analyses conducted with girls than those with 
boys, which again may have been due to the discrepancies in sample size. Interpretation 
of the present results should take into account these limitations, as well as the inherent 
variability introduced by combining different types of pain conditions into the same 
analyses. While Table 1 demonstrates the non-headache studies included in meta-analysis 
comprised primarily of patients with abdominal pain, the inclusion of other pain 
conditions may have an impact on the treatment response and potentially sex differences 
[45] . Similarly, the differences in type (e.g., migraine vs. tension-type) and frequency 
(e.g., episodic vs. chronic) of headache conditions may also have introduced 
heterogeneity that masks potential differences.  
Given the variability between the samples of boys and girls at pre-treatment, this 
raises questions around how best to consider pre-treatment sex differences. We encourage 
authors to consider the potential impact of sex in clinical trials, to incorporate sex into 
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their analyses where appropriate, and to consider pre-treatment sex differences. Findings 
related to sex differences may differ based on whether authors choose to report 
participant outcomes in relation to their own baseline (e.g., a 50% reduction in headache 
severity), as opposed to applying a standardized cut-off of treatment “success” to all 
participants (e.g., number of patients who reported headache pain less than a 3/10 on a 
numerical rating scale), which may inflate the appearance of treatment success among 
boys who had lower pain ratings at baseline. Increased reporting of sex- and gender-
related variables of the sample and therapist, and treatment dropouts would add to our 
understanding of the impact of sex and gender on treatment outcomes. Due to the 
potential for small effect sizes, sex difference research would generally benefit from 
recommendations to increase sample sizes in clinical trials, as well as including sex-
based analyses in meta-analyses of results [74] . Further research is required to determine 
whether observed differences between boys and girls are attributable to true differences 
in the experience of pain and related symptoms, versus sex differences in measurement 
and reporting. 
Though not possible here, future research would benefit from examining children 
and adolescents separately. Sex differences in chronic pain prevalence and some pain 
responses have been reported to emerge around the time of puberty, and therefore sex-
specific effects of psychological therapies may be stronger in adolescents than children  
[8,45] . Similar research should also be conducted in adult samples, and examining 
treatment outcomes beyond the core domains examined in the present review (e.g., sleep, 
treatment compliance and satisfaction, associated physical symptoms, health service 
utilization).  
 Finally, while the biological effects of sex likely have an influence on the 
response of individuals to psychological therapies for pain management, socially-
imposed gender roles and expectations can impact treatment efficacy and pain outcomes 
[2,59,62] . Future research would benefit from including measures of masculinity and 
femininity, taking a dimensional approach to the problem in question beyond the binary 
distinction of sex. 
 As chronic pain treatments advance towards providing personalized options, sex 
offers a dimension on which differences appear in general presentation prior to 
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commencing treatment and in the efficacy of the treatment. Such information may help to 
provide informed care decisions, and should encourage researchers to consider 
incorporating sex and other individual difference variables into the design and analyses of 
clinical trials.  
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(n = 523) *additional 44 
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(n = 484) 
Full-text articles 
assessed for eligibility 
(n = 39) 
Full-text articles 
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(n = 37) 
- Not an RCT: n = 5 
- Study protocol only: n = 1 
- Sample not chronic pain 
patients: n = 1 
- Study of adherence, not 
treatment: n = 1 
- Sample of adults: n = 8 
- Insufficient psychotherapeutic 
content: n = 2 
- Conference abstracts: n = 12 
- Not  available in English: n = 3 
- Dissertation: n = 1 
- Reporting on another study 
already included: n = 3 
Studies included in 
qualitative synthesis 
(n = 2 new studies + 44 
from original Cochrane 
reviews) 
Studies where authors 
provided data and were 
included in quantitative 
synthesis (meta-
analysis) 
(n = 17) 
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Table 1. Summary of characteristics of studies that were and were not included in meta-analysis.  







Studies included in meta-analysis 
Abram 2007 Headache 12.7 (10-18) 45 36 
Alfven 2007 Non-headache (abdominal pain) 9.9 (6-18) 36 12 
Balottin 2014 Headache 9.67 (6-18) 20 13 
Barry 1997 Headache 9.4 (7-12) 19 10 
Connelly 2006 Headache 10 (7-12) 18 19 
Groβ 2013 Non-headache (abdominal pain) 9.6 (7-12) 25 4 
Gulewitsch 2013 Non-headache (abdominal pain or irritable bowel 
syndrome) 
9.4 (6-12) 24 14 
Hechler 2014 Headache & Non-headache (abdominal pain, 
musculoskeletal pain, other) 
14 (9-17) 87 27 
Hicks 2006 Headache & Non-headache (abdominal pain) 11.7 (9-16) 30 17 
Kashikar-Zuck 2012 Non-headache (fibromyalgia) 15 (11-18) 105 9 
Levy 2010 Non-headache (abdominal pain) 11.21 (7-17) 145 55 
Palermo 2009 Headache & Non-headache (abdominal or 
musculoskeletal pain) 
14.8 (11-17) 35 13 
Powers 2013 Headache (migraine) 14.4 (10-17) 107 28 
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Rapoff 2014 Headache 10.2 (7-12) 25 10 
Stinson 2010 Non-headache (juvenile idiopathic arthritis) 14.6 (12-18) 31 15 
van der Veek 2013 Non-headache (abdominal pain) 11.9 (7-18) 75 29 
van Tilburg 2009 Non-headache (abdominal pain) 10.25 (6-15) 23 9 
Studies not included in meta-analysis 
Barakat 2010 Non-headache (sickle cell disease) 14.17 (12-18) 22 15 
Bussone 1998 Headache 11.4 (11-15) 17 18 
Cottrell 2007 Headache 14.1 (12-17) 15 15 
Duarte 2006 Non-headache (abdominal pain) 9.1 (5-13) 22 10 
Fitchel 2001 Headache 15.4 (13-18) 25 11 
Gil 1997 Non-headache (sickle cell disease) 11.9 (N/A) 23 26 
Griffiths 1996 Headache (migraine) 11.3 (10-12) 21 21 
Hickman 2015 Headache (13-17) 23 9 
Humphreys 2000 Non-headache (abdominal pain) 9.8 (4-18) 38 26 
Kashikar-Zuck 2005 Non-headache (fibromyalgia) 15.8 (13-17) 30 0 
Kroener-Herwig 2002 Headache (migraine, tension-type headache, combined) 12.1 (10-14) 34 41 
Labbe 1984 Headache (migraine) 10.8 (7-16) 14 14 
Labbe 1995 Headache (vascular or migraine) 12 (8-18) 13 17 
Larsson 1987a Headache (migraine, tension-type headache, or both) N/A (16-18) 40 6 
Larsson 1987b Headache 17 (16-18) 34 2 
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Larsson 1990 Headache 17 (16-18) 43 5 
Larsson 1996 Headache N/A (10-15) 25 1 
McGrath 1988 Headache 13.1 (11-18) 69 30 
McGrath 1992 Headache (migraine) N/A (11-18) 63 24 
Osterhaus 1997 Headache (migraine, tension-type headache, mixed) 15.2 (12-22) 29 10 
Passchier 1990 Headache 13.7 (N/A) 65 54 
Richter 1986 Headache (migraine) 12.9 (9-18) 34 17 
Robins 2005 Non-headache (abdominal pain) 11.4 (6-16) 39 30 
Sanders 1994 Non-headache (abdominal pain) 9.2 (7-14) 28 16 
Sartory 1998 Headache (migraine) 11.3 (8-16) 17 26 
Scharff 2002 Headache (migraine or tension-type headache) 12.8 (7-17) 24 12 
Trautmann 2010 Headache (migraine, tension-type headache, combined) 12.7 (10-18) 39 32 
Vlieger 2007 Non-headache (abdominal pain or irritable bowel 
syndrome) 
13.3 (8-18) 39 13 
Wicksell 2009 Headache & Non-headache (mixed) 14.8 (10-18) 25 7 
Note. N/A = not available. Number of girls and boys is reported at enrolment, including those that may have later dropped out of 
treatment (if available).  
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SMD[CI] Heterogeneity Effect 
Pain      
All chronic pain conditions 775 276 0.09 [-0.05,0.23] I2 = 0% Z = 1.24, p = .21 
Headache 310 126 0.26 [0.03,0.50] I2 = 9% Z = 2.24, p = .03 b 
Non-Headache 530 180 0.02 [-0.17,0.20] I2 = 5% Z = 0.16, p = .87 
Disability      
All chronic pain conditions 726 264 0.07 [-0.07,0.22] I2 = 2% Z = 0.98, p = .33 
Headache 300 130 0.08 [-0.14,0.29] I2 = 0% Z = 0.73, p = .47 
Non-Headache 461 147 0.18 [-0.06,0.41] I2 = 23% Z = 1.48, p = .14 
Anxiety      
All chronic pain conditions 435 129 0.38 [0.17,0.60] I2 = 6% Z = 3.56, p < .01 b 
Headache a - - - - - 
Non-Headache 379 112 0.42 [0.11,0.73] I2 = 40% Z = 2.66, p < .01 b 
Depression      
All chronic pain conditions 444 130 0.47 [0.24,0.70] I2 = 19% Z = 3.96, p < .01 b 
Headache 91 30 0.87 [0.44,1.30] I2 = 0% Z = 3.95, p < .01 b 
Non-Headache 388 113 0.35 [0.13,0.56] I2 = 0% Z = 3.15, p < .01 b 
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Note. a Insufficient data for meta-analysis; b Girls > Boys; SMD = standardized mean difference; CI = confidence interval 
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Table 3. Meta-analysis statistics of treatment effect for the post-treatment time point for boys and girls separately, and subgroup 
analyses examining sex differences. 
 
 Sample size SMD[CI] Heteroge-
neity 
Effect Subgroup analyses for sex 
differences 
Pain 
All chronic pain 
conditions 
      
 Girls n = 672 -0.27 [-0.47,-0.08]  I2= 29% Z = 2.74, p < .01a   
 Boys n = 239 -0.37 [-0.69,-0.05]  I2= 23% Z = 2.26, p = .02 a   
     χ2 = 0.25, p = .61, I2 = 0% 
 
Headache       
Severity Girls n = 295 -0.31 [-0.54,-0.08] I2= 0% Z = 2.60, p < .01 a   
 Boys n = 121 -0.48 [-0.94,-0.03] I2= 24% Z = 2.10, p = .04 a   
     χ2 = 0.45, p = .50, I2 = 0% 
 
Reduction of 
≥50% in headache 
severity 
     
SEX DIFFERENCES IN THERAPY FOR PEDIATRIC PAIN 
 
 43 
 Girls n = 295  1.81b [1.19,2.75]  I2= 13% Z = 2.77, p < .01 a  
 Boys n = 121 1.74 b [1.09,2.77] I2= 0% Z = 2.34, p = .02 a  
     χ2 = 0.01, p = .90, I2 = 0% 
 
Non-Headache       
 Girls n = 435 -0.31 [-0.59,-0.03]  I2= 44% Z = 2.19, p = .03 a   
 Boys n = 145 -0.49 [-0.98,-0.00] I2= 39% Z = 1.96, p = .05 a   
     χ2 = 0.39, p = .53, I2 = 0% 
 
Disability 
All chronic pain 
conditions 
      
 Girls n = 656 -0.40 [-0.62,-0.18] I2= 41% Z = 3.58, p < .01 a   
 Boys n = 223 -0.22 [-0.49,0.05] I2= 0% Z = 1.57, p = .12   
     χ2 = 1.05, p = .31, I2 = 4.5% 
 
Headache       
 Girls n = 276 -0.40 [-0.70,-0.09]  I2= 31% Z = 2.51, p = .01 a   
 Boys n = 109 -0.39 [-0.78,0.00] I2= 0% Z = 1.94, p = .05 a   
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     χ2 = 0.00, p = .98, I2 = 0% 
 
Non-Headache       
 Girls n = 415 -0.50 [-0.80,-0.20]  I2= 49% Z = 3.26, p < .01 a   
 Boys n = 127 -0.08 [-0.44,0.28]  I2= 0% Z = 0.44, p = .66   
     χ2 = 3.11, p = .08, I2 = 67.8% 
 
Anxietyc      
All chronic pain conditions       
 Girls n = 393  -0.21[-0.53,0.10] I2= 57% Z = 1.31, p = .19   
 Boys n = 117 -0.21 [-0.59,0.16] I2= 0% Z = 1.13, p = .26   
     χ2 = 0.00, p = .99, I2 = 0% 
 
Non-Headache       
 Girls n = 339 -0.06 [-0.28,0.16] I2= 3% Z = 0.57, p = .57   
 Boys n = 103 -0.35 [-0.75,0.05] I2= 0% Z = 1.70, p = .09   
     χ2 = 1.49, p = .22, I2 = 32.7% 
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Depression      
All chronic pain conditions       
 Girls n = 297 0.07 [-0.16,0.29] I2= 0% Z = 0.56, p = .57   
 Boys n = 104 -0.15 [-0.67,0.37] I2=39% Z = 0.57, p = .57   
     χ2 = 0.55, p = .46, I2 = 0% 
 
Headache       
 Girls n = 89 -0.00 [-0.43,0.42] I2= 0% Z = 0.02, p = .98   
 Boys n = 25 -0.23 [-1.02,0.57] I2= 0% Z = 0.56, p = .58   
     χ2 = 0.23, p = .63, I2 = 0% 
 
Non-Headache       
 Girls n = 243 0.06 [-0.19,0.32] I2= 0% Z = 0.49, p = .63   
 Boys n = 92 -0.11 [-0.67,0.44] I2= 34% Z = 0.40, p = .69   
     χ2 = 0.32, p = .57, I2 = 0% 
 
Note. SMD = standardized mean difference; CI = confidence interval 
a Treatment > Control 
b Value presented is the risk ratio, rather than standardised mean difference, as the outcome is dichotomous  
c Insufficient data to conduct headache-only analyses  
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Table 4. Meta-analysis statistics of treatment effect for the follow-up time point for boys and girls separately, and subgroup analyses 
examining sex differences. 
 
 Sample size SMD[CI] Heteroge-
neity 
Effect Subgroup analyses for sex 
differences 
Pain 
All chronic pain 
conditions 
      
 Girls n = 404 -0.21 [-0.51,0.09] I2= 51% Z = 1.37, p = .17   
 Boys n = 119 -0.06 [-0.42,0.31] I2= 0% Z = 0.30, p = .77   
     χ2 = 0.40, p = .53, I2 = 0% 
 
Headache       
Severity       
 Girls n = 119 -0.69 [-1.62,0.25] I2= 68% Z = 1.44, p = .15   
 Boys n = 37 -0.45 [-1.12,0.22] I2= 0% Z = 1.33, p = .18   
     χ2 = 0.16, p = .69, I2 = 0% 
 




≥50% in headache 
severity 
     
 Girls n = 119  1.97b [0.48,8.04] I2= 62% Z = 0.94, p = .34  
 Boys n = 37 2.01b [0.36,11.13] I2= 71% Z = 0.80, p = .42  
     χ2 = 0.00, p = 0.99, I2 = 0% 
 
Non-Headache       
 Girls n = 306 -0.20 [-0.57,0.17] I2= 58% Z = 1.06, p = .29   
 Boys n = 93 0.02 [-0.40,0.44] I2= 0% Z = 0.09, p = .92   
     χ2 = 0.60, p = .44, I2 = 0% 
 
Disability 
All chronic pain 
conditions 
      
 Girls n = 398 0.18 [-0.41,0.04] I2= 20% Z = 1.61, p = .11   
 Boys n = 123 -0.27 [-0.75,0.21] I2= 37% Z = 1.11, p = .27   
     χ2 = 0.11, p = .75, I2 = 0% 
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Headache       
 Girls n = 138  -0.40 [-0.74,-0.06] I2= 0% Z = 2.31, p = .02 a   
 Boys n = 54 -0.71 [-1.27,-0.16] I2= 0% Z = 2.52, p = .01 a   
     χ2 = 0.89, p = .35, I2 = 0% 
Non-Headache       
 Girls n = 260 -0.07 [-0.33,0.18] I2= 7% Z = 0.57, p = .57   
 Boys n = 69 0.07 [-0.41,0.55] I2= 0% Z = 0.28, p = .78   
     χ2 = 0.26, p = .61, I2 = 0% 
Anxietyc      
All chronic pain conditions       
 Girls n = 261 -0.09[-0.48,0.30] I2= 60% Z = 0.44, p = .66   
 Boys n = 70 -0.06 [-0.69,0.56] I2= 30% Z = 0.20, p = .84   
     χ2 = 0.00, p = .95, I2 = 0% 
 
Depressionc      
All chronic pain conditions       
 Girls n = 261 -0.07[-0.31,0.17] I2= 0% Z = 0.55, p = .58   
 Boys n = 70 0.21 [-0.27,0.69] I2= 0% Z = 0.86, p = .39   
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     χ2 = 1.03, p = .31, I2 = 3.2% 
Note. SMD = standardized mean difference; CI = confidence interval 
a Treatment > Control 
b Value presented is the risk ratio, rather than standardised mean difference, as the outcome is dichotomous  
c Insufficient data to conduct analyses for headache and non-headache separately  
 
 
 
